Kurt Diebold

Prospective Validation of Immunological Infiltrate for Prediction of Response to Neoadjuvant Chemotherapy in HER2-Negative Breast Cancer – A Substudy of the Neoadjuvant GeparQuinto Trial

Yasmin Issa-Nummer, Silvia Darb‐Esfahani, Sibylle Loibl et al. · PLoS ONE · 2013 · 226 citations · Full text

Medicine, Immunology, Oncology +17

Tumor-Infiltrating Lymphocytes: A Predictive and Prognostic Biomarker in Neoadjuvant-Treated HER2-Positive Breast Cancer

Barbara Ingold Heppner, Michael Untch, Carsten Denkert et al. · Clinical Cancer Research · 2016 · 202 citations

Medicine, Immunology, Oncology +16

Responsiveness of adjacent ductal carcinoma in situ and changes in HER2 status after neoadjuvant chemotherapy/trastuzumab treatment in early breast cancer—results from the GeparQuattro study (GBG 40)

Gϋnter von Minckwitz, Silvia Darb‐Esfahani, Sibylle Loibl et al. · Breast Cancer Research and Treatment · 2011 · 61 citations

Medicine, Oncology, Breast Oncology +14

Elemental bioimaging of haematoxylin and eosin-stained tissues by laser ablation ICP-MS

Olga Reifschneider, Christoph A. Wehe, Kurt Diebold et al. · Journal of Analytical Atomic Spectrometry · 2013 · 38 citations

Medicine, Oncology, Pathology +17

Laser ablation based bioimaging with simultaneous elemental and molecular mass spectrometry: towards spatially resolved speciation analysis

Christina Herdering, Christoph A. Wehe, Olga Reifschneider et al. · Rapid Communications in Mass Spectrometry · 2013 · 35 citations

Pharmacy, Biochemistry, Chemistry +17